Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
As with any question, we always stress that talking to your doctor is your first step. They will offer the best suggestions and information for your particular case.
Public health guidance has been changing rapidly and often, and we, like everyone else, are following closely the changes and recommendations for remaining healthy. Realizing that much of our community fall in to the 'immunocompromised' category, we thought it important to acknowledge the recent outbreak.
Dr. H. Jack West, GRACE Founder, President and CEO recently confirmed that there is really no cancer-specific recommendations, and that he and his colleagues are echoing the same recomendations as the CDC. There are no evidence-based recommendations to make outside of following guidance and recommended safety measures of the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We suggest adhering to CDC recommendations and protocols for heightened levels of cleanliness. For CDC guidelines outlining symptoms to look out for, please visit the CDC Symptoms of Coronavirus page.
A good article with advice for cancer patients, survivors and caregivers on who is most at risk for COVID-19 and what you can do to stay healthy, from the Fred Hutchinson Cancer Center in Seattle can be found here:
Be safe, be healthy.
Regards from the GRACE Staff
ASCO 2020 has been unfortunately cancelled. You can read their statement regarding COVID 19 here: https://meetings.asco.org/am/asco-statement-novel-coronavirus-covid-19
And more info from ASCO can be found here: https://www.asco.org/asco-coronavirus-information
More info from cancer.net - coronavirus-2019-what-people-with-cancer-need-know, available also in Spanish.
And common questions -common-questions-about-coronavirus-2019-and-cancer-answers-patients-and-survivors, also available in Spanish.
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: